This medical technology stock is back in a buy zone and nearing its all-time high.

Sequel Med Tech has a plan to explore a new type of ultra-concentrated and fast-acting insulin, to see how it may work with its automated pump and potentially offer a longer-lasting system for people ...

Bio-inspired medical devices can gather more data than ever before, and HPC/quantum will massively speed up discovery rates; consumer self-testing will be slower.

Medical technology is often viewed as a neutral tool for healing or curing; however, for many disabled people, it represents ...

Medical professionals don’t pursue careers in healthcare out of a love of data entry, but it’s an inescapable daily reality for most, taking time away from focused care and consultations with patients ...

Sequel Med Tech and Senseonics have announced a collaboration to integrate Sequel’s twiist Automated Insulin Delivery (AID) System with Senseonics’ Eversense 365 one-year Continuous Glucose Monitoring ...

CELZ-201-DDT is a proprietary allogeneic regenerative therapy designed to target the underlying pathology of DDD. Administered via ultrasound-guided injection, it offers a minimally invasive, ...

NYU Grossman School of Medicine’s Vilcek Institute of Graduate Biomedical Sciences offers PhD training in biomedical imaging.

This medical technology developer specializes in preserving organs for transplant. Its stock is in a cup-with-handle base.

April data and first quarter earnings reports show remarkable resilience in med tech, even as other sectors continue to suffer in response to tariffs and changing regulations. Not that tariffs proved ...

Med-tech companies raised a total of $25.37 billion in financings in 2024, up from $17.68 billion in 2023, though still significantly lower than previous years. The highest year for med-tech ...